<rss version="2.0">	<channel>		<title>FDA Approval</title>		<link>http://www.dentalplans.com/articles_rss/categoryrss8.xml</link>		<description>Articles</description>		<language>en-us</language>		<pubDate>Tue, 18 Nov 2008 17:15:03 GMT</pubDate><item>
	<title>Taxotere Receives FDA Approval for the Treatment of Patients with Head and Neck Cancer</title>
	<link>http://www.dentalplans.com/articles/5860/taxotere-receives-fda-approval-for-the-treatment-of-patients-with-head-and-neck-cancer.html</link>
	<description><![CDATA[<font size2>Bridgewater NJ ndash; October 18 2006 ndash; Sanofiaventis announced today that following a priority review of a supplemental new drug application sNDA the U.S. Food and Drug Administration FDA has approved Taxoterereg; doc...]]></description>
	<pubDate>Fri, 27 Oct 2006 16:40:22 GMT</pubDate>
	<CopyRight>HealthNewsDigestcom</CopyRight>
	<CopyRightYear>2006</CopyRightYear>
</item>

<item>
	<title>Advancis Pharmaceutical Receives FDA Approval Letter For New Strengths of Keflex</title>
	<link>http://www.dentalplans.com/articles/4650/advancis-pharmaceutical-receives-fda-approval-letter-for-new-strengths-of-keflex.html</link>
	<description><![CDATA[Advancis Pharmaceutical Corporation NASDAQ: AVNC a pharmaceutical company focused on developing and commercializing novel antiinfective products today announced that the U.S. Food and Drug Administration FDA has issued an Approval Letter in re...]]></description>
	<pubDate>Thu, 18 May 2006 09:44:20 GMT</pubDate>
	<CopyRight>HealthNewsDigestcom</CopyRight>
	<CopyRightYear>2006</CopyRightYear>
</item>

<item>
	<title>FDA Approves Rituxan The First Targeted B Cell Therapy for Treatment of Moderate to Severe Rheumatoid Arthritis</title>
	<link>http://www.dentalplans.com/articles/3628/fda-approves-rituxan-the-first-targeted-b-cell-therapy-for-treatment-of-moderate-to-severe-rheumatoid-arthritis.html</link>
	<description><![CDATA[Genentech Inc. NYSE: DNA and Biogen Idec Inc. Nasdaq: BIIB announced today that the U.S. Food and Drug Administration FDA has approved following Priority Review the therapeutic antibody Rituxan Rituximab in combination with methotrexate ...]]></description>
	<pubDate>Wed, 1 Mar 2006 12:31:44 GMT</pubDate>
	<CopyRight>HealthNewsDigestcom</CopyRight>
	<CopyRightYear>2006</CopyRightYear>
</item>

<item>
	<title>FDA Approves New Formulation of Imitrex Sumatriptan Succinate Injection</title>
	<link>http://www.dentalplans.com/articles/3514/fda-approves-new-formulation-of-imitrex-sumatriptan-succinate-injection.html</link>
	<description><![CDATA[The United States Food and Drug Administration FDA has approved a new formulation of Imitrex Injection that allows a convenient way for patients to take a 4mg dose using the Imitrex STATdose SystemR. Imitrex Injection is indicated for the acute t...]]></description>
	<pubDate>Tue, 7 Feb 2006 09:51:35 GMT</pubDate>
	<CopyRight>HealthNewsDigestcom</CopyRight>
	<CopyRightYear>2006</CopyRightYear>
</item>

<item>
	<title>FDA Approves New Treatment for Gastrointestinal and Kidney Cancer</title>
	<link>http://www.dentalplans.com/articles/3483/fda-approves-new-treatment-for-gastrointestinal-and-kidney-cancer.html</link>
	<description><![CDATA[The Food and Drug Administration FDA today announced approval of Sutent sunitinib a new targeted anticancer treatment for patients with gastrointestinal stromal tumors GIST a rare stomach cancer and advanced kidney cancer. Todays action ma...]]></description>
	<pubDate>Tue, 31 Jan 2006 11:02:00 GMT</pubDate>
	<CopyRight>HealthNewsDigestcom</CopyRight>
	<CopyRightYear>2006</CopyRightYear>
</item>

<item>
	<title>Food labels to list allergens</title>
	<link>http://www.dentalplans.com/articles/3103/food-labels-to-list-allergens.html</link>
	<description><![CDATA[Effective Jan. 1 2006 the Food and Drug Administration FDA is requiring food labels to state clearly if food products contain any ingredients that contain protein derived from the eight major allergenic foods.As a result of the Food Allerg...]]></description>
	<pubDate>Wed, 28 Dec 2005 08:07:22 GMT</pubDate>
	<CopyRight>MyDNAcom</CopyRight>
	<CopyRightYear>2006</CopyRightYear>
</item>

<item>
	<title>Lilly seeks FDA approval of Cymbalta for anxiety</title>
	<link>http://www.dentalplans.com/articles/3158/lilly-seeks-fda-approval-of-cymbalta-for-anxiety.html</link>
	<description><![CDATA[Ely Lilly announced that it plans to seek FDA approval to market its Cymbalta depression drug for the treatment of generalized anxiety disorder GAD. Backed by data from two clinical trials that support Cymbaltas use in the treatment of GAD Lilly ...]]></description>
	<pubDate>Wed, 28 Dec 2005 08:07:22 GMT</pubDate>
	<CopyRight>mydnacom</CopyRight>
	<CopyRightYear>2006</CopyRightYear>
</item>

<item>
	<title>Limited anticancer claims for tomatobased products</title>
	<link>http://www.dentalplans.com/articles/3291/limited-anti-cancer-claims-for-tomato-based-products.html</link>
	<description><![CDATA[The Food and Drug Administration FDA has rejected a proposal that would allow products containing lycopene to advertise the compound as a cancer inhibitor. Lycopene is an antioxidant found in food products such as tomatoes and watermelons.Th...]]></description>
	<pubDate>Wed, 28 Dec 2005 08:07:22 GMT</pubDate>
	<CopyRight>mydnacom</CopyRight>
	<CopyRightYear>2006</CopyRightYear>
</item>

<item>
	<title>FDA approves combination vaccine</title>
	<link>http://www.dentalplans.com/articles/2092/fda-approves-combination-vaccine.html</link>
	<description><![CDATA[Merck and Co. Inc. today announced that the U.S. Food and Drug Administration has approved the Companys combination vaccine PROQUADR Measles Mumps Rubella and Varicella Oka/Merck Virus Vaccine Live for simultaneous vaccination against measl...]]></description>
	<pubDate>Fri, 9 Sep 2005 09:14:04 GMT</pubDate>
	<CopyRight>HealthNewsDigestcom</CopyRight>
	<CopyRightYear>2005</CopyRightYear>
</item>

<item>
	<title>FDA Approves Tercicas Increlex for Short Stature Caused by Severe Primary IGF1 Deficiency</title>
	<link>http://www.dentalplans.com/articles/2038/fda-approves-tercicas-increlex-for-short-stature-caused-by-severe-primary-igf1-deficiency.html</link>
	<description><![CDATA[Tercica Inc.Nasdaq: TRCA announced today that the U.S. Food and Drug AdministrationFDA has approved IncrelexTM mecasermin rDNA origin injection for the longterm treatment of growth failure in children with severe primary IGF1 deficiency ...]]></description>
	<pubDate>Tue, 6 Sep 2005 11:13:34 GMT</pubDate>
	<CopyRight>HealthNewsDigestcom</CopyRight>
	<CopyRightYear>2005</CopyRightYear>
</item>

<item>
	<title>FDA Approves Enablex for Treatment of Overactive Bladder</title>
	<link>http://www.dentalplans.com/articles/1986/fda-approves-enablex-for-treatment-of-overactive-bladder.html</link>
	<description><![CDATA[Novartis Pharmaceuticals Corporation today announced that the U.S. Food and Drug Administration FDA has approved Enablex darifenacin extendedrelease tablets 7.5mg and 15mg for the treatment of overactive bladder OAB with symptoms of urge ur...]]></description>
	<pubDate>Thu, 1 Sep 2005 10:53:37 GMT</pubDate>
	<CopyRight>HealthNewsDigestcom</CopyRight>
	<CopyRightYear>2005</CopyRightYear>
</item>

<item>
	<title>Eloxatin Receives FDA Approval for the Treatment of Colon Cancer Following Surgery</title>
	<link>http://www.dentalplans.com/articles/1634/eloxatin-receives-fda-approval-for-the-treatment-of-colon-cancer-following-surgery.html</link>
	<description><![CDATA[SanofiSynthelabo a member of the sanofiaventis Group announced today that the US Food and Drug Administration FDA has approved ELOXATIN in combination with conventional chemotherapy infusional 5fluorouracil/leucovorin known as 5FU/LV for...]]></description>
	<pubDate>Fri, 12 Aug 2005 12:18:43 GMT</pubDate>
	<CopyRight>HealthNewsDigestcom</CopyRight>
	<CopyRightYear>2005</CopyRightYear>
</item>

<item>
	<title>FDA Approves Fosrenol to Reduce Phosphorus Levels in EndStage Renal Disease Patients</title>
	<link>http://www.dentalplans.com/articles/1588/fda-approves-fosrenol-to-reduce-phosphorus-levels-in-end-stage-renal-disease-patients.html</link>
	<description><![CDATA[Shire Pharmaceuticals Group plc NASDAQ: SHPGY LSE: SHP.L TSE: SHQ CN announced today that the United States Food and Drug Administration FDA has approved FOSRENOL lanthanum carbonate a noncalcium nonaluminum phosphate binder that reduces...]]></description>
	<pubDate>Thu, 11 Aug 2005 09:51:01 GMT</pubDate>
	<CopyRight>HealthNewsDigestcom</CopyRight>
	<CopyRightYear>2005</CopyRightYear>
</item>

<item>
	<title>FDA Approves First Artificial Disc for Treatment of Low Back Pain</title>
	<link>http://www.dentalplans.com/articles/1587/fda-approves-first-artificial-disc-for-treatment-of-low-back-pain.html</link>
	<description><![CDATA[The U.S. Food and Drug Administration FDA has approved the CHARIT Artificial Disc a device that treats severe low back pain by replacing a damaged or worn out spinal disc with an artificial one according to DePuy Spine Inc. a Johnson  Johnson...]]></description>
	<pubDate>Thu, 11 Aug 2005 09:47:18 GMT</pubDate>
	<CopyRight>HealthNewsDigestcom</CopyRight>
	<CopyRightYear>2005</CopyRightYear>
</item>

<item>
	<title>FDA Approves Diovan valsartan to Reduce Cardiovascular Death in Heart Attack Survivors at High Risk</title>
	<link>http://www.dentalplans.com/articles/1470/fda-approves-diovan-valsartan-to-reduce-cardiovascular-death-in-heart-attack-survivors-at-high-risk.html</link>
	<description><![CDATA[Novartis Pharmaceuticals Corporation announced today that the US Food and Drug Administration FDA approved Diovan valsartan the most prescribed ARB angiotensin receptor blocker in the US and worldwide for a new indication to reduce cardiovas...]]></description>
	<pubDate>Fri, 5 Aug 2005 09:17:16 GMT</pubDate>
	<CopyRight>HealthNewsDigestcom</CopyRight>
	<CopyRightYear>2005</CopyRightYear>
</item>

<item>
	<title>FDA Expands Indication for ADDERALL XR CII Confirming Safety and Efficacy in Adolescents</title>
	<link>http://www.dentalplans.com/articles/1311/fda-expands-indication-for-adderall-xr-cii-confirming-safety-and-efficacy-in-adolescents.html</link>
	<description><![CDATA[Philadelphia US  July 22 2005  Shire Pharmaceuticals Group plc LSE: SHP NASDAQ: SHPGY TSX: SHQ announced today that the US Food and Drug Administration FDA has approved ADDERALL XR mixed salts of a singleentity amphetamine product as a ...]]></description>
	<pubDate>Tue, 26 Jul 2005 10:08:19 GMT</pubDate>
	<CopyRight>HealthNewsDigestcom</CopyRight>
	<CopyRightYear>2005</CopyRightYear>
</item>

<item>
	<title>Sipping Soft Drinks and Other Beverages Reduces Risk of Decay</title>
	<link>http://www.dentalplans.com/articles/1196/sipping-soft-drinks-and-other-beverages-reduces-risk-of-decay.html</link>
	<description><![CDATA[Americans drink roughly 576 soft drinks every year  about one and a half cans a day for everyone in the United States. Drinking these beverages places the people who may not follow proper oral hygiene techniques at a higher risk for cavities and oth...]]></description>
	<pubDate>Mon, 11 Jul 2005 12:55:05 GMT</pubDate>
	<CopyRight>HealthNewsDigestcom</CopyRight>
	<CopyRightYear>2005</CopyRightYear>
</item>

<item>
	<title>Sipping Soft Drinks and Other Beverages Reduces Risk of Decay</title>
	<link>http://www.dentalplans.com/articles/1195/sipping-soft-drinks-and-other-beverages-reduces-risk-of-decay.html</link>
	<description><![CDATA[Americans drink roughly 576 soft drinks every year  about one and a half cans a day for everyone in the United States. Drinking these beverages places the people who may not follow proper oral hygiene techniques at a higher risk for cavities and oth...]]></description>
	<pubDate>Mon, 11 Jul 2005 12:54:24 GMT</pubDate>
	<CopyRight>HealthNewsDigestcom</CopyRight>
	<CopyRightYear>2005</CopyRightYear>
</item>

<item>
	<title>Schering Plough Announces FDA Approval of Avelox MOXIFLOXACIN HCL for Treatment of Complicated Skin and Skin Structure Infections</title>
	<link>http://www.dentalplans.com/articles/1161/schering-plough-announces-fda-approval-of-avelox-moxifloxacin-hcl-for-treatment-of-complicated-skin-and-skin-structure-infections.html</link>
	<description><![CDATA[ScheringPlough Corporation NYSE: SGP today announced that the U.S. Food and Drug Administration FDA has approved the oncedaily antibiotic AVELOX moxifloxacin HCl for the treatment of complicated skin and skin structure infections cSSSI in ...]]></description>
	<pubDate>Wed, 6 Jul 2005 12:40:36 GMT</pubDate>
	<CopyRight>HealthNewsDigestcom</CopyRight>
	<CopyRightYear>2005</CopyRightYear>
</item>

<item>
	<title>FDA Approves Vesicare solifenacin succinate for the Treatment of Overactive Bladder</title>
	<link>http://www.dentalplans.com/articles/1146/fda-approves-vesicare-solifenacin-succinate-for-the-treatment-of-overactive-bladder.html</link>
	<description><![CDATA[Vesicare solifenacin succinate has been approved by the U.S. Food and Drug Administration FDA for the treatment of overactive bladder OAB with symptoms of urgency frequency and urge incontinence. In clinical studies Vesicare 5 mg and 10 mg ...]]></description>
	<pubDate>Tue, 5 Jul 2005 12:28:37 GMT</pubDate>
	<CopyRight>HealthNewsDigestcom</CopyRight>
	<CopyRightYear>2005</CopyRightYear>
</item>

<item>
	<title>First Laser Gum Disease Procedure to gain FDA Clearance</title>
	<link>http://www.dentalplans.com/articles/1115/first-laser-gum-disease-procedure-to-gain-fda-clearance.html</link>
	<description><![CDATA[50 people out of 100 have moderate to severe gum disease 40 out of the 50 dont know it and only 3 people out of 100 will ever get treated before its too late.Gum disease is a silent painless chronic communicable bacterial infection t...]]></description>
	<pubDate>Fri, 1 Jul 2005 11:33:15 GMT</pubDate>
	<CopyRight>HealthNewsDigestcom</CopyRight>
	<CopyRightYear>2005</CopyRightYear>
</item>

<item>
	<title>FDA Approves Updated Labeling for COREG</title>
	<link>http://www.dentalplans.com/articles/973/fda-approves-updated-labeling-for-coreg.html</link>
	<description><![CDATA[GlaxoSmithKline NYSE: GSK announced today that the U.S. Food and Drug Administration approved the addition of important clinical data to the labeling for its betablocker Coreg carvedilol. One of the updates to the label is based on a study show...]]></description>
	<pubDate>Wed, 1 Jun 2005 17:03:18 GMT</pubDate>
	<CopyRight>HealthNewsDigestcom</CopyRight>
	<CopyRightYear>2005</CopyRightYear>
</item>

<item>
	<title>FDA Approves REMICADE for Ninth Indication Psoriatic Arthritis</title>
	<link>http://www.dentalplans.com/articles/861/fda-approves-remicade-for-ninth-indication--psoriatic-arthritis.html</link>
	<description><![CDATA[Centocor Inc. announced today that the U.S. Food and Drug Administration FDA has approved REMICADE infliximab to reduce the signs and symptoms of active arthritis in patients with psoriatic arthritis. An immunemediated inflammatory disease ps...]]></description>
	<pubDate>Thu, 19 May 2005 16:36:55 GMT</pubDate>
	<CopyRight>HealthNewsDigestcom</CopyRight>
	<CopyRightYear>2005</CopyRightYear>
</item>

<item>
	<title>FDA Approves First Portable NonEgg Device to Monitor of REM Stage Sleep</title>
	<link>http://www.dentalplans.com/articles/456/fda-approves-first-portable-non-egg-device-to-monitor-of-rem-stage-sleep.html</link>
	<description><![CDATA[The Food and Drug Administration FDA has now approved a new diagnostic technology which can increase our capacity to diagnosis sleep disorders which affect over 40 million Americans and have devastating clinical economic and social consequences ...]]></description>
	<pubDate>Mon, 7 Mar 2005 14:10:44 GMT</pubDate>
	<CopyRight>HealthNewsDigestcom</CopyRight>
	<CopyRightYear>2005</CopyRightYear>
</item>

<item>
	<title>Members of FDA Advisory Committees Support Safety of Naproxen</title>
	<link>http://www.dentalplans.com/articles/422/members-of-fda-advisory-committees-support-safety-of-naproxen.html</link>
	<description><![CDATA[Bayer HealthCares Consumer Care Division said today it was pleased that discussions by the U.S. Food and Drug Administration FDA Arthritis and Drug Safety and Risk Management Advisory Committees clarified conflicting reports about the safety of Al...]]></description>
	<pubDate>Mon, 28 Feb 2005 09:53:57 GMT</pubDate>
	<CopyRight>HealthNewsDigestcom</CopyRight>
	<CopyRightYear>2005</CopyRightYear>
</item>

<item>
	<title>LDR Spine Receives FDA 510k Clearance for Easyspine Spinal System and BF Bone Substitute</title>
	<link>http://www.dentalplans.com/articles/395/ldr-spine-receives-fda-510k-clearance-for-easyspine-spinal-system-and-bf--bone-substitute.html</link>
	<description><![CDATA[LDR Spine a total spine solution company today announced that it has obtained 510k clearance from the United States Food and Drug Administration to market two of its fusion spine products in the U.S. LDR Spine will formally introduce U.S. surgeon...]]></description>
	<pubDate>Wed, 23 Feb 2005 10:40:43 GMT</pubDate>
	<CopyRight>HealthNewsDigestcom</CopyRight>
	<CopyRightYear>2005</CopyRightYear>
</item>

<item>
	<title>FDA Approves New Dosing Options for Prevacid</title>
	<link>http://www.dentalplans.com/articles/145/fda-approves-new-dosing-options-for-prevacid.html</link>
	<description><![CDATA[TAP Pharmaceutical Products Inc. announced today that the U.S. Food and Drug Administration FDA has approved PREVACID lansoprazole SoluTab DelayedRelease Orally Disintegrating Tablets to be given using an oral syringe or nasogastric NG tube. ...]]></description>
	<pubDate>Wed, 19 Jan 2005 11:44:14 GMT</pubDate>
	<CopyRight>HealthNewsDigestcom</CopyRight>
	<CopyRightYear>2005</CopyRightYear>
</item>

<item>
	<title>Say No To Nausea </title>
	<link>http://www.dentalplans.com/articles/104/say-no-to-nausea-.html</link>
	<description><![CDATA[The next time you or someone you know is nauseated by motion sickness morning sickness chemotherapy or surgery relief may come from a surprising spot. Constant gentle pressure on the inner wrist has long been known to relieve feelings of nausea. <...]]></description>
	<pubDate>Wed, 19 Jan 2005 10:40:55 GMT</pubDate>
	<CopyRight>HealthNewsDigestcom</CopyRight>
	<CopyRightYear>2005</CopyRightYear>
</item>

<item>
	<title>FDA Approves Aldara </title>
	<link>http://www.dentalplans.com/articles/87/fda-approves-aldara-.html</link>
	<description><![CDATA[3M announced today that the U.S. Food and Drug Administration FDA has approved the first prescription therapy in nearly a decade for the treatment of superficial basal cell carcinoma sBCC a type of nonmelanoma skin cancer. AldaraTM imiquimod...]]></description>
	<pubDate>Tue, 18 Jan 2005 16:36:07 GMT</pubDate>
	<CopyRight>HealthNewsDigestcom</CopyRight>
	<CopyRightYear>2005</CopyRightYear>
</item>

<item>
	<title>VISX CustomVue Hyperopia Procedure Approved by the FDA</title>
	<link>http://www.dentalplans.com/articles/52/visx-customvue-hyperopia-procedure-approved-by-the-fda.html</link>
	<description><![CDATA[VISX INCORPORATED NYSE Symbol: EYE today announced that it has received approval from the U.S. Food and Drug Administration FDA to treat hyperopia also known as farsightedness and astigmatism with the VISX CustomVue laser vision correction pro...]]></description>
	<pubDate>Tue, 18 Jan 2005 14:54:12 GMT</pubDate>
	<CopyRight>HealthNewsDigestcom</CopyRight>
	<CopyRightYear>2005</CopyRightYear>
</item>

<item>
	<title>FDA Approves Orthofix for CervicalStim</title>
	<link>http://www.dentalplans.com/articles/51/fda-approves-orthofix-for-cervical-stim.html</link>
	<description><![CDATA[Orthofix now is the only company that can offer surgeons and their patients a full range of FDAapproved clinically effective noninvasive stimulation products for healing the cervical and lumbar spine and longbone fractures.We expect t...]]></description>
	<pubDate>Tue, 18 Jan 2005 14:52:55 GMT</pubDate>
	<CopyRight>HealthNewsDigestcom</CopyRight>
	<CopyRightYear>2005</CopyRightYear>
</item>

<item>
	<title>Shire receives US FDA approval of EQUETROTM for Bipolar Disorder</title>
	<link>http://www.dentalplans.com/articles/50/shire-receives-us-fda-approval-of-equetrotm-for-bipolar-disorder.html</link>
	<description><![CDATA[Shire Pharmaceuticals Group plc LSE: SHP NASDAQ: SHPGY TSX: SHQ announces that the US Food  Drug Administration FDA has approved EQUETROTM extendedrelease carbamazepine capsules previously known as SPD417 for the treatment of patients w...]]></description>
	<pubDate>Tue, 18 Jan 2005 14:49:10 GMT</pubDate>
	<CopyRight>HealthNewsDigestcom</CopyRight>
	<CopyRightYear>2005</CopyRightYear>
</item>

	</channel></rss>